 | Up a level |
Garcia-Tsao, Guadalupe; Bosch, Jaime; Kayali, Zeid; Harrison, Stephen A; Abdelmalek, Manal F; Lawitz, Eric; Satapathy, Sanjaya K; Ghabril, Marwan; Shiffman, Mitchell L; Younes, Ziad H; Thuluvath, Paul J; Berzigotti, Annalisa; Albillos, Agustin; Robinson, James M; Hagerty, David T; Chan, Jean L; Sanyal, Arun J (2020). Randomized Placebo-Controlled Trial of Emricasan in Non-alcoholic Steatohepatitis (NASH) Cirrhosis with Severe Portal Hypertension. Journal of hepatology, 72(5), pp. 885-895. Elsevier 10.1016/j.jhep.2019.12.010
Garcia-Tsao, Guadalupe; Fuchs, Michael; Shiffman, Mitchell; Borg, Brian B; Pyrsopoulos, Nikolaos; Shetty, Kirti; Gallegos-Orozco, Juan F; Reddy, K Rajender; Feyssa, Eyob; Chan, Jean L; Yamashita, Mason; Robinson, James M; Spada, Alfred P; Hagerty, David T; Bosch, Jaime (2019). Emricasan (IDN-6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Hypertension. Hepatology, 69(2), pp. 717-728. Wiley Interscience 10.1002/hep.30199
